News
Wegovy uses the same active ingredient (semaglutide ... dosing for weight loss and diabetes management, and how does it differ from Wegovy's? Experts weighed in, and we provided an Ozempic dosing ...
Single dose of Vivani’s NPM-139 semaglutide implant led to nearly 20% weight loss in rats, suggesting once- or twice-yearly dosing. NPM-139 showed steady semaglutide release with potential for ...
ALAMEDA, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical ...
NanoPortal™ technology successfully delivers semaglutide, the active ingredient ... administration with expected once or twice-yearly dosing NPM-139 is a miniature, subdermal implant in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results